|
1
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: analysis of incidence, outcome, and
associated costs of care. Crit Care Med. 29:1303–1310. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fry DE: Sepsis, systemic inflammatory
response, and multiple organ dysfunction: the mystery continues. Am
Surg. 78:1–8. 2012.PubMed/NCBI
|
|
3
|
Ware LB and Matthay MA: The acute
respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matthay MA and Zemans RL: The acute
respiratory distress syndrome: pathogenesis and treatment. Annu Rev
Pathol. 6:147–163. 2011. View Article : Google Scholar :
|
|
5
|
Matthay MA and Zimmerman GA: Acute lung
injury and the acute respiratory distress syndrome: four decades of
inquiry into pathogenesis and rational management. Am J Respir Cell
Mol Biol. 33:319–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Erickson SE, Martin GS, Davis JL, Matthay
MA and Eisner MD; NIH NHLBI ARDS Network: Recent trends in acute
lung injury mortality: 1996–2005. Crit Care Med. 37:1574–1579.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zimmerman JJ, Akhtar SR, Caldwell E and
Rubenfeld GD: Incidence and outcomes of pediatric acute lung
injury. Pediatrics. 124:87–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hudson LD, Milberg JA, Anardi D and
Maunder RJ: Clinical risks for development of the acute respiratory
distress syndrome. Am J Respir Crit Care Med. 151:293–301. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gando S: Microvascular thrombosis and
multiple organ dysfunction Syndrome. Crit Care Med. 38(Suppl 2):
S35–S42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levi M and van der Poll T: Inflammation
and coagulation. Crit Care Med. 38(Suppl 2): S26–S34. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersson U, Wang H, Palmblad K, et al:
High mobility group 1 protein (HMG-1) stimulates proinflammatory
cytokine synthesis in human monocytes. J Exp Med. 192:565–570.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Bloom O, Zhang M, et al: HMG-1 as
a late mediator of endotoxin lethality in mice. Science.
285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Yang H and Tracey KJ:
Extracellular role of HMGB1 in inflammation and sepsis. J Intern
Med. 255:320–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fiuza C, Bustin M, Talwar S, et al:
Inflammation-promoting activity of HMGB1 on human microvascular
endothelial cells. Blood. 101:2652–2660. 2003. View Article : Google Scholar
|
|
15
|
Mullins GE, Sunden-Cullberg J, Johansson
AS, et al: Activation of human umbilical vein endothelial cells
leads to relocation and release of high-mobility group box
chromosomal protein 1. Scand J Immunol. 60:566–573. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bae JS and Rezaie AR: Activated protein C
inhibits high mobility group box 1 signaling in endothelial cells.
Blood. 118:3952–3959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yasuda T, Ueda T, Takeyama Y, et al:
Significant increase of serum high-mobility group box chromosomal
protein 1 levels in patients with severe acute pancreatitis.
Pancreas. 33:359–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gibot S, Massin F, Cravoisy A, et al:
High-mobility group box 1 protein plasma concentrations during
septic shock. Intensive Care Med. 33:1347–1353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gaïni S, Pedersen SS, Koldkjaer OG,
Pedersen C and Møller HJ: High mobility group box-1 protein in
patients with suspected community-acquired infections and sepsis: a
prospective study. Crit Care. 11:R322007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Zoelen MA, Laterre PF, van Veen SQ, et
al: Systemic and local high mobility group box 1 concentrations
during severe infection. Crit Care Med. 35:2799–2804. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karlsson S, Pettilä V, Tenhunen J,
Laru-Sompa R, Hynninen M and Ruokonen E: HMGB1 as a predictor of
organ dysfunction and outcome in patients with severe sepsis.
Intensive Care Med. 34:1046–1053. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silva E, Arcaroli J, He Q, et al: HMGB1
and LPS induce distinct patterns of gene expression and activation
in neutrophils from patients with sepsis-induced acute lung injury.
Intensive Care Med. 33:1829–1839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang XJ, Luan ZG and Ma XC: shRNAs
targeting high-mobility group box-1 inhibit E-selectin expression
via homeobox A9 in human umbilical vein endothelial cells. Mol Med
Rep. 7:1251–1256. 2013.PubMed/NCBI
|
|
24
|
Luan ZG, Zhang XJ, Yin XH, et al:
Downregulation of HMGB1 protects against the development of acute
lung injury after severe acute pancreatitis. Immunobiology.
218:1261–1270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cannon JG, Tompkins RG, Gelfand JA, et al:
Circulating interleukin-1 and tumor necrosis factor in septic shock
and experimental endotoxin fever. J Infect Dis. 161:79–84. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Minamino T and Komuro I: Regeneration of
the endothelium as a novel therapeutic strategy for acute lung
injury. J Clin Invest. 116:2316–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rakonczay Z Jr, Hegyi P, Takács T,
McCarroll J and Saluja AK: The role of NF-kappaB activation in the
pathogenesis of acute pancreatitis. Gut. 57:259–267. 2008.
View Article : Google Scholar
|
